Skip to main navigation Skip to search Skip to main content

Ciprofloxacin Metabolites Drive Resistance Development and Biofilm Changes in Pseudomonas aeruginosa and Staphylococcus aureus

Research output: Contribution to journal › Article › peer-review

Abstract

Objectives: To investigate how two major ciprofloxacin metabolites, 2-oxo ciprofloxacin (M 3) and N-formyl ciprofloxacin (M 4), influence the resistance profiles and biofilm characteristics of Pseudomonas aeruginosa (PAO1) and Staphylococcus aureus (ATCC 25923). Methods: Both metabolites were synthesised, structurally validated, and co-cultured with bacterial strains at subinhibitory concentrations over a 30-d period. Minimum inhibitory concentration (MIC) assays, crystal violet biofilm quantification, and genomic and transcriptomic analyses (whole-genome and differential RNA sequencing) were employed to assess phenotypic and molecular adaptations. Results: Exposure to ciprofloxacin metabolites altered bacterial behaviour despite their weak intrinsic antimicrobial activity. In S. aureus, continuous exposure to M 3 and M 4 resulted in an eight- and fourfold increase, respectively, in ciprofloxacin MIC values. In P. aeruginosa, although MIC values remained unchanged, prolonged exposure to both metabolites enhanced biofilm formation, M 4 (P < 0.0001) and M 3 (P < 0.0089). Genomic sequencing of P. aeruginosa revealed a missense mutation (A290D) in the wspA gene following M 3 exposure, which activates biofilm-promoting pathways via cyclic-di-GMP signalling. RNA sequencing identified 220 differentially expressed genes, including upregulation of quorum-sensing regulators (rhlI, pqsH), nitric oxide cycle genes (nir, norCB), and the pel operon. Conclusions: Ciprofloxacin metabolites, though less potent than the parent antibiotic, can drive adaptive responses linked to resistance and persistence. Their capacity to induce stable genetic and transcriptomic shifts underscores their potential ecological and clinical significance as underexplored factors in antimicrobial resistance.

Original languageEnglish (Ireland)
Pages (from-to)412-419
Number of pages8
JournalJournal of Global Antimicrobial Resistance
Volume50
DOIs
Publication statusPublished - Sept 2026

Keywords

  • AMR
  • Antibiotic metabolites
  • Biofilms
  • Ciprofloxacin
  • Pseudomonas aeruginosa
  • Staphylococcus aureus

Fingerprint

Dive into the research topics of 'Ciprofloxacin Metabolites Drive Resistance Development and Biofilm Changes in Pseudomonas aeruginosa and Staphylococcus aureus'. Together they form a unique fingerprint.

Cite this